A global leader in women’s health, Hologic enables people to lead healthier lives everywhere, every day, with options for screening, detection and treatment. The Diagnostic Solutions division delivers on this commitment by developing and providing cytology, molecular and perinatal testing. The Hologic STI Portfolio supports sexual and vaginal health testing needs through innovative technology and rigorously developed assays, including the Aptima Combo 2® (CT/NG) assay, Aptima® Mycoplasma genitalium assay, Aptima® Trichomonas vaginalis assay, Aptima® BV and CV/TV assay and the Aptima® HSV 1&2 assay. Our Panther® instrumentation and Aptima® and Panther Fusion® assays help guide patient care and enable earlier detection because accurate diagnosis helps prevent the spread of disease and protects reproductive health. We are dedicated to improving patient care through solutions that provide greater peace of mind for you and your patients.